BriaCell Therapeutics Corp.

BCTX · NASDAQ
Analyze with AI
7/31/2025
7/31/2024
7/31/2023
7/31/2022
Operating Activities
Net Income-$36-$7-$27-$34
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$3$10-$5-$0
Other Non-Cash-$0-$36$0$19
Operating Cash Flow-$39-$33-$32-$16
Investing Activities
PP&E Inv.$0-$1$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$11-$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$11-$1$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$63$6$5$8
Stock Repurch.$0$0-$0-$13
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$0
Financing Cash Flow$63$6$5-$5
Forex Effect-$0-$0$0-$0
Net Chg. in Cash$13-$28-$26-$21
Supplemental Information
Beg. Cash$1$29$54$73
End Cash$14$1$28$53
Free Cash Flow-$39-$34-$32-$16
BriaCell Therapeutics Corp. (BCTX) Financial Statements & Key Stats | AlphaPilot